Home / Recalls / Viatris Inc / D-0603-2024

D-0603-2024 Class II

Recalled by Viatris Inc — Canonsburg, PA

Recall Details

Product Type
Drugs
Report Date
July 24, 2024
Initiation Date
April 30, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
3,694 bottles

Product Description

Cardura XL (doxazosin) extended release tablets 8mg, 30-count bottles, Rx Only Made in Singapore, Distributed by Roerig Division of Pfizer Inc, NY, NY 10017 NDC 0049-2080-10

Reason for Recall

Failed Impurities/Degradation Specifications

Distribution Pattern

U.S. Nationwide

Code Information

Lot#: 8147041; Exp. June 2024 Lot#: 8163765; Exp. March 2025

Other recalls by Viatris Inc

  • D-0204-2025 Class II — Cardura XL (doxazosin) extended release tablets 4 mg, 30 -count bottle, Rx only, (December 23, 2024)
  • D-0203-2025 Class II — Cardura XL (doxazosin) extended release tablets 8 mg, 30-count bottle, Rx only, (December 23, 2024)
  • D-0119-2025 Class II — Levothyroxine Sodium Tablets USP, 137 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0124-2025 Class II — Levothyroxine Sodium Tablets USP, 50 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0127-2025 Class II — Levothyroxine Sodium Tablets USP, 100 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0128-2025 Class II — Levothyroxine Sodium Tablets USP, 112 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)
  • D-0125-2025 Class II — Levothyroxine Sodium Tablets USP, 75 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0123-2025 Class II — Levothyroxine Sodium Tablets USP, 25 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0126-2025 Class II — Levothyroxine Sodium Tablets USP, 88 mcg, packaged in a) 90-count bottles (NDC 0 (November 18, 2024)
  • D-0121-2025 Class II — Levothyroxine Sodium Tablets USP, 175 mcg, packaged in a) 90-count bottles (NDC (November 18, 2024)